AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Metcalf, R. G
Right arrow Articles by Cleland, L. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metcalf, R. G
Right arrow Articles by Cleland, L. G
Agricola
Right arrow Articles by Metcalf, R. G
Right arrow Articles by Cleland, L. G
American Journal of Clinical Nutrition, Vol. 85, No. 5, 1222-1228, May 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Effects of fish-oil supplementation on myocardial fatty acids in humans1,2,3

Robert G Metcalf, Michael J James, Robert A Gibson, James RM Edwards, John Stubberfield, Robert Stuklis, Kurt Roberts-Thomson, Glenn D Young and Leslie G Cleland

1 From the Rheumatology Unit (RGM, MJJ, and LGC), the Cardiothoracic Surgery Unit (JRME, JS, and RS), and the Cardiovascular Research Centre (GDY and KR-T), Royal Adelaide Hospital, Adelaide, Australia; the School of Agriculture Food and Wine (RAG) and the School of Medicine (MJJ, LGC, and GDY), University of Adelaide, Adelaide, Australia; and the Hanson Institute, Adelaide, Australia (MJJ and LGC)

Background: Increased fish or fish-oil consumption is associated with reduced risk of cardiac mortality, especially sudden death. This benefit putatively arises from the incorporation of the long-chain n–3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) into cardiomyocyte phospholipids.

Objective: The study examined the kinetics of incorporation of n–3 fatty acids into human myocardial membrane phospholipids during supplementation with fish oil and {alpha}-linolenic acid–rich flaxseed oil.

Design: Patients with low self-reported fish intake (<1 fish meal/wk and no oil supplements) accepted for elective cardiac surgery involving cardiopulmonary bypass were randomly allocated to 1 of 6 groups: no supplement; fish oil (6 g EPA+DHA/d) for either 7, 14, or 21 d before surgery; flaxseed oil; or olive oil (both 10 mL/d for 21 d before surgery). Right atrial appendage tissue removed during surgery and blood collected at enrollment and before surgery were analyzed for phospholipid fatty acids.

Results: Surgery rescheduling resulted in a range of treatment times from 7 to 118 d. In the fish-oil-treated subjects, accumulation of EPA and DHA in the right atrium was curvilinear with time and reached a maximum at {approx}30 d of treatment and displaced mainly arachidonic acid. Flaxseed oil supplementation yielded a small increase in atrial EPA but not DHA, whereas olive oil did not significantly change atrial n–3 fatty acids.

Conclusion: The results of the present study show that dietary n–3 fatty acids are rapidly incorporated into human myocardial phospholipids at the expense of arachidonic acid during high-dose fish-oil supplementation.

Key Words: Fish oils • fatty acids • n–3 fatty acids • dietary fats • myocardium • humans







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition